In vivo evaluation and dosimetry of 123I-2-iodo-D-phenylalanine, a new potential tumor-specific tracer for SPECT, in an R1M rhabdomyosarcoma athymic mouse model

Journal of Nuclear Medicine

Volumn 46, Issue 12, 2005, Pages 2104-2111

  Kersemans, Veerle ^a,e   Cornelissen, Bart ^a,b   Bacher, Klaus ^a   Kersemans, Ken ^c   Thierens, Hubert ^a   Dierckx, Rudi A ^d   De Spiegeleer, Bart ^a   Slegers, Guido ^a   Mertens, John ^c  

^a GHENT UNIVERSITY   (Belgium)

^b UNIVERSITY OF TORONTO   (Canada)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

^e NONE   (Canada)

Author keywords

123I 2 iodo D phenylalanine; Biodistribution; D amino acid; Radiolabeled amino acid analog; Tumor imaging

Indexed keywords

2 IODO DEXTRO PHENYLALANINE I 123; 2 IODO DEXTRO PHENYLALANINE I 125; 2 IODO PHENYLALANINE I 123; 2 IODO TYROSINE I 123; COPPER ION; FLUORODEOXYGLUCOSE F 18; HUMAN SERUM ALBUMIN I 123; TRACER; UNCLASSIFIED DRUG; 2 IODOPHENYLALANINE; 2-IODOPHENYLALANINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; PHENYLALANINE; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT;

ABDOMEN; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER; BRAIN; CONTROLLED STUDY; DOSE CALCULATION; DOSE RESPONSE; DOSIMETRY; DRUG ACCUMULATION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG SCREENING; DRUG SPECIFICITY; DRUG STABILITY; DRUG UPTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMAGING SYSTEM; IN VIVO STUDY; INFLAMMATION; ISOTOPE LABELING; KIDNEY CLEARANCE; LOW ENERGY RADIATION; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ANIMAL; CALIBRATION; CLUSTER ANALYSIS; DISEASE MODEL; EVALUATION; HUMAN; IMAGE PROCESSING; KINETICS; METHODOLOGY; RADIATION DOSE; RADIOMETRY; SCINTISCANNING; TIME;

ANIMALS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLUSTER ANALYSIS; DISEASE MODELS, ANIMAL; EVALUATION STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INFLAMMATION; IODINE RADIOISOTOPES; KINETICS; MALE; MICE; MICE, NUDE; PHENYLALANINE; RADIATION DOSAGE; RADIOMETRY; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; RHABDOMYOSARCOMA; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33644874041     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Jager PL, Vaalburg W, Pruim J, et al. Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med. 2001;42:432-445.
2. Yanagida O, Kanai Y, Chairoungdua A, et al. Human L-type amino acid transport system 1 (LAT1): characterisation of function and expression in tumor cell lines. Biochim Biophys Acta. 2001;1514:291-302.
3. 125I-2-iodo-L-phenylalanine in an R1M rhabdomyosarcoma athymic mouse model as a potential tumor tracer for SPECT. J Nucl Med. 2005;46:532-539.
4. 11C-labeled D-amino acids into tumor bearing animals. Gann. 1978;69:517-523.
5. 11C- labelled D-amino acids by various tumors. Gann. 1982;73:147-152.
6. Mertens JJR, Kersemans V, Lahoutte T, et al. Radioiodo-D-2-I- phenylalanine: a new tumor specific tracer for diagnosis and systemic radionuclide therapy [abstract]. Eur J Nucl Med. 2004;31(suppl):S220.
7. Waterton JC, Alott CP, Pickfort R, et al. Assessment of mouse tumor xenograft volumes in vivo by ultrasound imaging, MRI and calliper measurement. In: Faulkner K, Carey B, Crellin A, Harisson RM, eds. Proceedings of the 19th LH Gray Conference: Quantitative Imaging in Oncology. London, U.K.: Kluwer Academic Publishers; 1997:146-149.
8. Boellaard R, Krak NC, Hoekstra OS, Lammertsma AA. Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study. J Nucl Med. 2004;45:1519-1527.
9. Thie JA. Understanding the standarized uptake value, its methods, and implications for usage. J Nucl Med. 2004;45:1431-1434.
10. 123I]Iodo-alpha- methyl-L-tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol. 2002;29:625-631.
11. Loevinger R, Budinger T, Watson E. MIRD Primer for Absorbed Dose Calculations. New York, NY: Society of Nuclear Medicine; 1991:1-17.
12. Cloutier RJ, Smith SA, Watson EE, Snyder WS, Warner GG. Dose to the fetus from radionuclides in the bladder. Health Phys. 1973;25:147-161.
13. 123I-2-iodo- L-tyrosine [abstract]. J Nucl Med. 2005;46(suppl):355P.
14. Cook MJ. The Anatomy of the Laboratory Mouse. New York, NY: Academic Press; 1965:55-78.
15. 125I]-2-iodo-L-phenylalanine in a R1M rhabdomyosarcoma cell model as a new potential tumor tracer for SPECT. Nucl Med Biol. 2004;31:739-746.
16. Rutgers M, Buitenhuis CKM, Hoefnagel CA, et al. Targeting of meta-iodobenzylguanidine to SK-N-SH human neuroblastoma xenografts: tissue distribution, metabolism and therapeutic efficacy. Int J Cancer. 2000;87:412-422.
17. Hoefnagel CA, Lewington VJ. MIBG therapy. In: Murray IPC, Ell PJ, eds. Nuclear Medicine in Clinical Diagnosis and Treatment. 2nd ed. London, U.K.: Churchill Livingstone; 1998:1067-1081.
18. 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma. J Clin Oncol. 1998;16:229-236.
19. Tyr deacylase: stereospecificity of the translation machine revisited. FEBS Lett. 2003;552:95-98.
20. Beekhuis H. Population radiation absorbed dose from nuclear medicine procedures in the Netherlands. Health Phys. 1988;54:287-291.